Community Health Sys Inc SEC Filings

Community Health Systems, Inc. (CYH)13,171,818 shares of CYH common stock, representing 9.5% of the outstanding shares based on 138,519,615 shares outstanding as of October 17, 2025.

The ownership is held through numerous Apollo funds and managed vehicles, including credit, absolute return and specialty funds, all listed as “Reporting Persons.” Each reporting entity has shared voting and dispositive power over its respective shares and no sole voting or dispositive power. The Apollo entities and certain executives formally disclaim beneficial ownership of the reported shares beyond their indirect roles, and certify that the securities were not acquired to change or influence control of Community Health Systems, consistent with a passive investment filing under Schedule 13G.

CastleKnight/Weitman group filed an amended Schedule 13G reporting a passive stake in Community Health Systems (CYH). The filing shows beneficial ownership of 12,262,508 shares of Class A common stock, representing 8.8% of the class as of 09/30/2025.

The reporting persons report shared voting and dispositive power over 12,262,508 shares and no sole voting or dispositive power. They certify the securities were not acquired and are not held for the purpose of changing or influencing control.

Community Health Systems (CYH) entered a material definitive agreement to sell its 80% interests in two Clarksville, Tennessee joint ventures (including Tennova Healthcare - Clarksville) to Vanderbilt University Medical Center and its subsidiaries. The purchase price is $600 million, payable at closing and subject to adjustments for closing net working capital and amounts due to the joint ventures from CHS.

The buyer already holds minority stakes and will acquire the remaining interests through this transaction. Closing is expected in early 2026, subject to regulatory approvals and other closing conditions. Either party may terminate if the deal is not consummated by December 31, 2026. At closing, the parties plan to enter into transition services agreements for information technology and operational support.

A press release announcing the agreement was issued the same day and filed as an exhibit. The agreement includes customary representations, warranties, covenants, and indemnification provisions.

Community Health Systems (CYH) affiliate filed a Form 144 notice to sell 532,813 shares of common stock on the NYSE, with an aggregate market value of $2,226,625. The proposed sales are listed through UBS Financial Services Inc. with an approximate sale date of October 28, 2025.

Shares outstanding were 138,519,615; this is a baseline figure, not the amount being sold. The filing lists prior acquisition of the securities primarily via RSU and PSU grants from the issuer across 2013–2023.

Community Health Systems (CYH) reported a return to profitability in Q3 2025. Net operating revenues were $3,087 million, essentially flat year over year. Income from operations was $243 million versus a loss of $205 million a year ago. Net income attributable to stockholders was $130 million, or $0.96 diluted EPS, compared with a loss of $391 million, or $(2.95) diluted EPS.

For the nine months, revenues were $9,379 million and net income attributable to stockholders was $399 million, or $2.97 diluted EPS, versus a loss of $446 million, or $(3.38) diluted EPS, last year. Results reflect a net gain of approximately $242 million from divestitures year to date and a Q3 income tax benefit of about $163 million tied to federal legislation. Interest expense was $216 million in Q3.

Cash from operations reached $277 million year to date. Asset sales provided $1,012 million of proceeds. Long‑term debt declined to $10,589 million from $11,432 million at year‑end, supported by refinancing, including $700 million of 10.75% senior secured notes due 2033 and $1.790 billion of 9.75% senior secured notes due 2034, alongside tenders/redemptions of 2027 and 2028 notes.

Community Health Systems (CYH) furnished an update via an 8-K announcing operating results for the third quarter ended September 30, 2025. The company also provided updated 2025 annual earnings guidance in a press release attached as Exhibit 99.1.

The guidance reflects the company’s historical operating performance, current trends and other assumptions outlined in the press release on pages 16–20. The information in this report (including the exhibit) is deemed furnished, not filed.

Apollo-related entities filed Amendment No.1 to a Schedule 13G reporting collective ownership of Common Stock of Community Health Systems, Inc. (CUSIP 203668108). The filing shows that Apollo Capital Management, L.P. and affiliated reporting persons beneficially own 7,628,576 shares, representing 5.4% of the outstanding class based on 140,119,116 shares. Ownership is reported as shared voting and dispositive power; no reporting person claims sole voting or sole dispositive power. Individual Apollo-managed funds and vehicles hold smaller stakes, ranging from 0.0% to 3.0% for Credit Strategies (4,212,955 shares). The filing includes organizational details and disclaimers of beneficial ownership by certain managers and officers.